“PREEKLAMPSIYA KUZATILGAN HOMILADORLARDA AKUSHERLIK VA PERINATAL ASORATLARNI PROGNOZLASH”.
Article Sidebar
Main Article Content
Аннотация:
Preeklampsiya kuzatilgan homiladorlarda biokimyoviy va gemostaziologik markyorlarning miqdorini aniqlash va shunga ko‘ra, homiladorlarda akusherlik va perinatal asoratlar rivojlanishini prognozlash.
Article Details
Как цитировать:
Библиографические ссылки:
“Homiladorlik davrida arterial gipertenziyani olib borish bo‘yicha milliy klinik bayonnoma ” 22.03.2021 yil;
WHO U, UNFPA, World Bank Group and the United Nations Population Division, author, Trends in Maternal Mortality 2000 to 2017.2019;
“Onalar va bolalar salomatligini muhofaza qilish, aholining reproduktiv salomatligini mustahkamlash chora-tadbirlari to‘g‘risida” PQ-296-son 08/09/2023
Alisse Hauspurg, MD; Arun Jeyabalan, MD “Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy” American Journal of Obstetrics & Gynecology S1211-1221 FEBRUARY 2022
L.Saleh; M.M.Alblas; D.Nieboer; R.I.Neuman; Y.Vergouwe; I.A.Brusse ; J.J.Duvekot ; E.W.Steyerberg; H.J.Versendaal ; A.H.Danser; A.H.Van Den Meiracker; K.Verdonk; W.Visser. “Prediction of pre-eclampsia-related complications in women with suspected or confirmed pre-eclampsia: development and internal validation of clinical prediction model” Ultrasound Obstet Gynecol 2021; 58; 698-704
S.R.Adizova “Preeklampsiya asoratlarni bashoratlashda biokimyoviy markerlarning klinik ahamiyati” Doktor axborotnomasi №4(108)-2022
Opichka, M.A.; Rappelt, M.W.; Gutterman, D.D.; Grobe, J.L.; McIntosh, J.J. Vascular Dysfunction in Preeclampsia. Cells 2021, 10, 3055.
Eunjung JUNG, MD, Roberto ROMERO, MD, DMedSci1, Lami YEO, MD, Nardhy GOMEZ-LOPEZ, PhD, Piya CHAEMSAITHONG, MD, PhD, Adithep JAOVISIDHA, MD, Offer EREZ, MD” The etiology of preeclampsia” Am J Obstet Gynecol. 2022 February; 226(2 Suppl): S844–S866. doi:10.1016/j.ajog.2021.11.1356.
Curr. Issues Mol. Biol. 2023, 45, 6202–6215. Sara Tabacco, Silvia Ambrosii, Valentina Polsinelli, Ilaria Fantasia, Angela D’Alfonso, Manuela Ludovisi, Sandra Cecconi, and Maurizio Guido “Pre-Eclampsia: From Etiology and Molecular Mechanisms to Clinical Tools—A Review of the Literature” Curr. Issues Mol. Biol. 2023, 45, 6202–6215.
Mol, B.W.J.; Roberts, C.T.; Thangaratinam, S.; Magee, L.A.; de Groot, C.J.M.; Hofmeyr, G.J. Pre-Eclampsia. Lancet 2016, 387, 999–1011.
Portelli, M.; Baron, B. Clinical presentation of preeclampsia and the diagnostic value of proteins and their methylation productsas biomarkers in pregnant women with preeclampsia and their newborns. J. Pregnancy 2018, 2018, 2632637.
Rana, S.; Lemoine, E.; Granger, J.P.; Karumanchi, S.A. Preeclampsia: Pathophysiology, challenges, and perspectives. Circ. Res.2019, 124, 1094–1112.
Herraiz, I.; Llurba, E.; Verlohren, S.; Galindo, A.; Spanish Group for the Study of Angiogenic Markers in Preeclampsia. Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the SFlt-1/PlGF Ratio in Singleton Pregnancies. Fetal Diagn. Ther.2018, 43, 81–89.
Loudon, I. Some historical aspects of toxaemia of pregnancy. A Rev. BJOG 1991, 98, 853–858.
Lai, J.; Romero, R.; Tarca, A.L.; Iliodromiti, S.; Rehal, A.; Banerjee, A.; Yu, C.; Peeva, G.; Palaniappan, V.; Tan, L. SARS-COV-2 and the subsequent development of preeclampsia and preterm birth: Evidence of a dose response relationship supporting causality.Am. J. Obstet. Gynecol. 2021, 225, 689–693.
Conde-Agudelo, A.; Villar, J.; Lindheimer, M. Maternal infection and risk of preeclampsia: Systematic review and metaanalysis.Am. J. Obestet. Gynecol. 2008, 198, 7–22.
Easter, S.R.; Cantonwine, D.E.; Zera, C.A.; Lim, K.H.; Parry, S.I.; McElrath, T.F. Urinary tract infection during pregnancy,
angiogenic factor profiles, and risk of preeclampsia. Am. J. Obestet. Gynecol. 2016, 214, 387.e1–387.e7.
Tambyah, P.A.; Maki, D.G. Catheter-associated urinary tract infection is rarely symptomatic: A prospective study of 1497
catheterized patients. Arch. Intern. Med. 2000, 160, 678–682.
Herraiz, I.; Llurba, E.; Verlohren, S.; Galindo, A.; Spanish Group for the Study of Angiogenic Markers in Preeclampsia. Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the SFlt-1/PlGF Ratio in Singleton Pregnancies. Fetal Diagn. Ther.2018, 43, 81–89.
LaMarca, B.D.; Ryan, M.J.; Gilbert, J.S.; Murphy, S.R.; Granger, J.P. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr. Hypertens. Rep. 2007, 9, 480–485.
Sutton, E.F.; Lob, H.E.; Song, J.; Xia, Y.; Butler, S.; Liu, C.-C.; Redman, L.M.; Sones, J.L. Adverse metabolic phenotype of female offspring exposed to preeclampsia in utero: A characterization of the BPH/5 mouse in postnatal life. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2017, 312, R485–R491.
Schneider, S.; Freerksen, N.; Röhrig, S.; Hoeft, B.; Maul, H. Gestational diabetes and preeclampsia—Similar risk factor profiles Early Hum. Dev. 2012, 88, 179–184.
Rachael Fox, Jamie Kitt, Paul Leeson, Christina YL Aye, Adam J Lewandowski “Preeclampsia: Risk Factors, Diagnosis, Management, and the Cardiovascular Impact on the Offspring” J Clin Med. 2019 Oct 4;8(10):1625
V. TSATSARIS (Paris) “Preeclampsia: Update on epidemiologic parameters, etiology and management”
Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005 Jun 10;308(5728):1592-4.
Акушерство: национальное руководство / под ред. Г. М. Савельевой, Г. Т. Сухих, В. Н. Серова, В. Е. Радзинского. - 2-е изд, перераб. и доп. - М.: ГЭОТАР-Медиа, 2018. - 1088 с. - (Серия, “Национальные руководства”). - ISBN 978-5-9704-4551-8.
Alisse Hauspurg, MD; Arun Jeyabalan, MD “Postpartum preeclampsia or eclampsia:defining its place and management among the hypertensive disorders of pregnancy”.